Home
Scholarly Works
A 24-Week, Randomized, Treat-to-Target Trial...
Journal article

A 24-Week, Randomized, Treat-to-Target Trial Comparing Initiation of Insulin Glargine Once-Daily With Insulin Detemir Twice-Daily in Patients With Type 2 Diabetes Inadequately Controlled on Oral Glucose-Lowering Drugs

Abstract

OBJECTIVE: To determine whether glargine is noninferior to detemir regarding the percentage of patients reaching A1C <7% without symptomatic hypoglycemia

Authors

Swinnen SG; Dain M-P; Aronson R; Davies M; Gerstein HC; Pfeiffer AF; Snoek FJ; DeVries JH; Hoekstra JB; Holleman F

Journal

Diabetes Care, Vol. 33, No. 6, pp. 1176–1178

Publisher

American Diabetes Association

Publication Date

June 1, 2010

DOI

10.2337/dc09-2294

ISSN

0149-5992

Contact the Experts team